Profiel
Michael Alfieri worked as a Controller at Merrimack Pharmaceuticals from 2014 to 2017.
He then worked as a Controller & Executive Director-Finance at Anika Therapeutics from 2010 to 2014.
In 2017, he worked as a Vice President-Finance at Radius Health.
In 2018, he worked as VP-Finance, Chief Financial & Accounting Officer at Genocea Biosciences.
Mr. Alfieri received his undergraduate and graduate degrees from Bentley University.
Eerdere bekende functies van Michael Alfieri
| Bedrijven | Functie | Einde |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01-05-2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-01-2017 |
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-07-2014 |
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 05-03-2019 |
Opleiding van Michael Alfieri
| Bentley University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
